Treat Bio accelerates veterinary pharmaceutical research by replacing traditional livestock-focused trial infrastructure with a tech-enabled platform built for home-based pets. The company handles study design, recruitment, management, analysis, and regulatory support, leveraging a waitlist of thousands of pet parents to enroll real companion animals in clinical trials. Their AI-enabled Treat Platform streamlines participant coordination, achieving lower drop-off rates than industry standards.
Funding
Funding not disclosed
Founders
Product
Problem
Current veterinary contract research organizations were designed for the livestock industry, expecting large farms with thousands of identical animals. Companion pets are different—they live in homes, have diverse breeds and lifestyles, and require individualized attention—making traditional trial infrastructure inefficient, costly, and poorly suited for studying naturally occurring diseases in dogs and cats.
Solution
Treat Bio provides comprehensive, fast, and affordable clinical trial support specifically for pet research. The company designs studies using data from thousands of prior trials, recruits real home-based pets from a large waitlist of pet parents, and manages the entire process through the Treat Platform—a tech-first, AI-enabled system that coordinates hundreds of individual stakeholders. Treat Bio also offers in-house bioinformatics for complex datasets spanning microbiome, blood, palatability, and urine tests, plus regulatory support through connections with leading institutions. This approach delivers trials approximately 4x faster and at a fraction of traditional costs while maintaining high clinical and pre-publication standards.
Target Audience
Primary customers are veterinary pharmaceutical, biotech, and pet nutrition companies conducting clinical trials for drugs, supplements, or diagnostic products in companion animals.
Features
- Study design services using historical trial data to determine optimal sample sizes, trial formats (RCT, blinded, crossover), and cost-effective test selection
- Recruitment from a waitlist of thousands of home-based pets, with targeting capabilities by breed, age, diet, and disease condition
- AI-enabled Treat Platform for streamlined study management, coordinating hundreds of individual participants and veterinary partners
- Lower participant drop-off rates than industry standards through close veterinary collaboration and individualized attention
- In-house bioinformatics and technical teams capable of analyzing complex datasets including microbiome, blood, palatability, and urine tests
- Regulatory support leveraging connections with leading institutions and regulatory bodies to handle compliance needs